-
1
-
-
0035869407
-
Use of chemotherapy plus a monoclonal antibody against her2 for metastatic breast cancer that overexpresses HER2
-
DOI 10.1056/NEJM200103153441101
-
Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L: Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344:783-792, 2001. (Pubitemid 32222155)
-
(2001)
New England Journal of Medicine
, vol.344
, Issue.11
, pp. 783-792
-
-
Slamon, D.J.1
Leyland-Jones, B.2
Shak, S.3
Fuchs, H.4
Paton, V.5
Bajamonde, A.6
Fleming, T.7
Eiermann, W.8
Wolter, J.9
Pegram, M.10
Baselga, J.11
Norton, L.12
-
2
-
-
0003683804
-
-
Herceptin (Trastuzumab)
-
Herceptin (Trastuzumab). Product Information. 1998.
-
(1998)
Product Information
-
-
-
3
-
-
0033506258
-
Infusion reactions associated with the therapeutic use of monoclonal antibodies in the treatment of malignancy
-
DOI 10.1023/A:1006341717398
-
Dillman RO: Infusion reactions associated with the therapeutic use of monoclonal antibodies in the treatment of malignancy. Cancer Metastasis Rev 18:465-471, 1999. (Pubitemid 30365324)
-
(1999)
Cancer and Metastasis Reviews
, vol.18
, Issue.4
, pp. 465-471
-
-
Dillman, R.O.1
-
4
-
-
0022628844
-
Toxicities and side effects associated with intravenous infusions of murine monoclonal antibodies
-
Dillman RO, Beauregard JC, Halpern SE, Clutter M: Toxicities and side effects associated with intravenous infusions of murine monoclonal antibodies. J Biol Response Mod 5:73-84, 1986. (Pubitemid 16167631)
-
(1986)
Journal of Biological Response Modifiers
, vol.5
, Issue.1
, pp. 73-84
-
-
Dillman, R.O.1
Beauregard, J.C.2
Halpern, S.E.3
Clutter, M.4
-
5
-
-
0024151871
-
Toxicities associated with monoclonal antibody infusions in cancer patients
-
Dillman RO, Beauregard JC, Jamieson M, Amox D, Halpern SE: Toxicities associated with monoclonal antibody infusions in cancer patients. Mol Biother 1:81-85, 1988.
-
(1988)
Mol Biother
, vol.1
, pp. 81-85
-
-
Dillman, R.O.1
Beauregard, J.C.2
Jamieson, M.3
Amox, D.4
Halpern, S.E.5
-
6
-
-
0028095919
-
The acute phase response
-
DOI 10.1016/0167-5699(94)90137-6
-
Baumann H, Gauldie J: The acute phase response. Immunol Today 15:74-80, 1994. (Pubitemid 24049800)
-
(1994)
Immunology Today
, vol.15
, Issue.2
, pp. 74-80
-
-
Baumann, H.1
Gauldie, J.2
-
8
-
-
0027374786
-
Hydrocortisone regulation of interleukin-6 protein production by a purified population of human peripheral blood monocytes
-
DOI 10.1006/clin.1993.1171
-
Breuninger LM, Dempsey WL, Uhl J, Murasko DM: Hydrocortisone regulation of interleukin-6 protein production by a purified population of human peripheral blood monocytes. Clin Imrnunol [rnmunopathol 69:205-214, 1993. (Pubitemid 23319389)
-
(1993)
Clinical Immunology and Immunopathology
, vol.69
, Issue.2
, pp. 205-214
-
-
Breuninger, L.M.1
Dempsey, W.L.2
Uhl, J.3
Murasko, D.M.4
-
9
-
-
0027485803
-
Corticosteroids differentially regulate secretion of IL6, IL-8, and G-CSF by a human bronchial epithelial cell line
-
Levine SJ, Larivee P, Logun C, Angus CW, Shelhamer JH: Corticosteroids differentially regulate secretion of IL6, IL-8, and G-CSF by a human bronchial epithelial cell line. Am J Physio1265:360-368, 1993.
-
(1993)
Am J Physio
, vol.1265
, pp. 360-368
-
-
Levine, S.J.1
Larivee, P.2
Logun, C.3
Angus, C.W.4
Shelhamer, J.H.5
-
10
-
-
0023574619
-
Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells
-
Knudsen PJ, Dinarello CA, Strom TB: Glucocorticolds inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J Immunol 139:4129-4134, 1987. (Pubitemid 18013709)
-
(1987)
Journal of Immunology
, vol.139
, Issue.12
, pp. 4129-4134
-
-
Knudsen, P.J.1
Dinarello, C.A.2
Strom, T.B.3
-
11
-
-
0031664666
-
Rapid tumor lysis in a patient with B-cell chronic lymphocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC C2B8, rituximab)
-
DOI 10.1007/s002770050419
-
Jensen M, Winker U, Manzke O, Diehl V, Engert A: Rapid tumor lysis in a patient with B-cell chronic lymphocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab). Ann Hemato177:89-91, 1998. (Pubitemid 28425183)
-
(1998)
Annals of Hematology
, vol.77
, Issue.1-2
, pp. 89-91
-
-
Jensen, M.1
Winkler, U.2
Manzke, O.3
Diehl, V.4
Engert, A.5
|